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Abstract
We analyzed the survival responses and downstream signaling elicited by GDNF on sympathetic
neurons from different Ret knockin mice. Lack of tyrosine 1062, a multidocking site in Ret,
completely prevented GDNF-mediated survival. Importantly lack of tyrosine 981, although
abrogating Akt phosphorylation, had no effect on neuronal survival, indicating that the PI 3-K/Akt
pathway is not necessary for survival of sympathetic neurons. In contrast, silencing of B-Raf
completely prevented not only GDNF-mediated but also NGF-mediated cell survival, independently
of MEK-1/2. We identified IKKs as the main effectors of the protective effects of B-Raf. First, B-
Raf interacted with and activated IKKs. Second, knockdown of IKKs reversed the protection afforded
by a constitutively active form of B-Raf. Third, knockdown of IKKs prevented both NGF- and
GDNF-mediated survival. In conclusion, our data delineate a novel survival pathway for sympathetic
neurons linking B-Raf to IKKs, independently of both PI 3-K and MEK-1/2 pathways.
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INTRODUCTION
The GDNF family ligands (GFLs) constitute a group of neurotrophic factors (GDNF, NRTN,
PSPN, ARTN) that regulate several aspects of the developing nervous system. GDNF and
NRTN were identified by virtue of their ability to promote the survival of cultured ventral
mesencephalic dopaminergic neurons and sympathetic neurons, respectively. The spectrum of
neuronal populations which survive in response to GFLs has been broadened and now includes
sensory, motor, parasympathetic and enteric neurons 1
GFLs signal through a common tyrosine kinase receptor (Ret), and one of the four co-receptors
known as GFRα1–4. Ret is alternatively spliced to produce at least two variants of identical
sequence up to residue 1063, followed by a unique C-terminal sequence composed of either 9
or 51 amino acids (Ret9 and Ret51) (reviewed in 2). Ret has five important tyrosines which
serve as docking sites for downstream effectors. Tyr905 binds Grb10 and Grb7, whereas
Tyr981 binds Src, Abl and SHB-β. Phospholipase C-γ and Grb2 bind to Tyr1015 and Tyr1096
(which is only present in Ret 51), respectively. Finally, Tyr1062 is a multidocking site which
binds Shc, IRS-1, FRS-2 and Dok4/5/6 (reviewed in 1).
After phosphorylation of docking tyrosines and binding to the adequate adaptors, engagement
of RTKs leads to the activation of signaling pathways that are ultimately responsible for the
biological effects. Among them, the phosphatydilinositol 3 -kinase (PI 3-K)/Akt and the
extracellular-related kinase 1 and 2 (ERK1/2) pathways have been shown to convey pro-
survival signals in many different systems. Since Ret was an orphan receptor for years, most
of our knowledge of its signaling properties comes from the analysis of its oncogenic forms.
Thus, the relevance of the signaling pathways elicited by ligand-activated endogenous, wild
type Ret, in neuronal function is largely unexplored. On the other hand the signaling pathways
by which NGF, another neurotrophic factor for sympathetic neurons, promotes their survival
is controversial, as opposed reports on the role of the PI 3-K/Akt had been published.3–6
We have previously generated knockin mice expressing point mutants of either Ret9 or Ret51
of human origin. These included tyrosine-to-phenylalanine mutations of residues 981, 1015
and 1062 7. In the present work, we aim to elucidate the signaling pathways important for
survival of sympathetic neurons using such mutants and GDNF-mediated survival as readout.
Our data reveal a critical role for tyrosine 1062, but not tyrosines 981 or 1015, in neuronal
survival. Notably, lack of Ret tyrosine 981 impairs Akt phosphorylation but has no effect on
cell survival, indicating that the PI 3-K/Akt pathway is not necessary for GDNF-mediated
survival of sympathetic neurons. Instead, we find that a novel B-Raf/IKK pathway mediates
the pro-survival effects of not only GDNF but importantly also NGF in sympathetic neurons.
RESULTS
Neurons from mice expressing Ret9 or Ret51 display similar responses to GDNF
As mentioned above, two Ret splicing isoforms that differ at the carboxy terminus have been
identified (Ret9 and Ret51). We wanted to analyze whether such differences affected Ret
downstream signaling or bioactivity in sympathetic neurons. We first verified that neurons
expressed the expected Ret isoforms by immunoprecipitating Ret from cultured sympathetic
neurons from mice expressing either wild type Ret9 or Ret51 (Figure 1A). We next checked
the activation of the PI 3-K/Akt and Ras/MAPK pathways. Lysates from neurons stimulated
with GDNF for ten minutes were probed with phosphoantibodies specific for phosphorylated
Ser473 Akt and dually phosphorylated ERK1/2. No differences between RetRET9 or
RetRET51 knockin mice and their wild type littermates were detected, despite the observation
that mutant mice appeared to express slightly less Ret than wild type animals (Figure 1B).
Finally, we analyzed the survival response prompted by GDNF on neurons from RetRET9 and
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RetRET51 mice. As shown in Figure 1C, GDNF promoted the survival of 80–90% of neurons
from both RetRET9 and RetRET51 knockin mice, a response which was similar to that of their
wild type littermates. This survival response was also comparable to NGF-dependent survival
of both mutant and wild type neurons. In summary, despite the differences between Ret9 and
Ret51, the two splicing isoforms appear to elicit similar biological responses to GDNF in
sympathetic neurons.
Akt and ERK1/2 activation are differentially affected by the mutation of tyrosines 981, 1015
or 1062 in the context of Ret9
To ascertain the role of Ret tyrosines 981, 1015 and 1062 in GDNF-mediated downstream
signaling in sympathetic neurons, we checked the activation of both Akt and ERK1/2 after
acute (10 minutes) stimulation with GDNF in lysates from mice lacking the above tyrosines,
and compared mutant mice with their wild type littermates. In the context of Ret9, lack of
tyrosine 981 caused an almost complete abrogation of Akt phosphorylation together with a
remarkable but less drastic reduction in ERK1/2 activation. Mutation of tyrosine 1015, on the
other hand, decreased both Akt and ERK1/2 phosphorylation to approximately a half, whereas
sympathetic neurons from RetRET9(Y1062F) mice showed no activation of either pathway above
the baseline (Figure 2). Essentially the same results were obtained when GDNF stimulation
was performed for 24 h (Supplemental Figure 1). Surprisingly, none of the three mutations
caused a significant change in the pattern of phosphorylation of either Akt or ERK1/2 in the
context of Ret51 (data not shown and 7).
These data, together with the observation that mice expressing either Ret51(Y1062F) or
truncated Ret51 lacking Tyr1096 develop normal kidneys, whereas Y1062F mutation
introduced in Ret9 results in kidney agenesis 7, suggest that Tyr1096 plays a redundant role
in Ret signaling. To characterize the effects of mutations of Ret tyrosines 981, 1015 and 1062
without the confounding effects of redundant signaling by the carboxy terminus of Ret51, we
performed further studies only in the context of the Ret9 isoform.
Mutation of tyrosine 1062, but not 981 or 1015 abrogates GDNF-mediated survival
Having shown that mutation of tyrosines 981, 1015 and 1062 in Ret9 decreased downstream
signaling, we sought to analyze the effects of their absence on GDNF-mediated neuronal
survival. Surprisingly, neurons from RetRET9(Y981F) mice did not show any reduction on
GDNF-mediated survival (Figure 3, left column and Supplemental Figure 1), despite causing
almost no phosphorylation of Akt. Neurons survived to levels similar to those achieved by
their wild type littermates or by neurons from RetRET9mice. The survival response was similar
to that elicited by NGF, and lasted at least up to 7 days, the last time point analyzed (Figure 3,
right column and Supplemental Figure 2). Neurons from RetRET9(Y1015F) mice showed a similar
response, i.e., full rescue by GDNF (Figure 3 and Supplemental Figure 2), whereas mutation
of tyrosine 1062 completely prevented GDNF-mediated survival. Neurons expressing this
mutation responded normally to NGF, demonstrating that the effect was specific for GDNF
(Figure 3). Thus, although mutation of tyrosines 981 and 1015 diminished the activation of
both Akt and ERK1/2, only mutation of tyrosine 1062 prevented GDNF-mediated survival of
sympathetic neurons.
Neither the PI 3-K/Akt nor the MEK/ERK pathways are necessary for GDNF-mediated survival
Since the reduction of Akt phosphorylation in neurons from RetRET9(Y981F) animals did not
correlate with a decrease in cell survival, we directly tested the role of the PI 3-K pathway on
GDNF-mediated survival of sympathetic neurons. Addition of increasing doses of LY294002,
a selective inhibitor of PI 3-K, did not kill a significant number of wild type neurons when
compared to vehicle-treated cells. The same doses inhibited Akt phosphorylation to basal levels
suggesting a complete blockade of GDNF-mediated PI 3-K signaling (Figure 4A).
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PDK1 is a “master” kinase linking PI 3-K activation to its more relevant downstream effectors,
namely Akt and other members of the AGC family of kinases (reviewed in 8). Consistent with
the results obtained with LY294002, lentiviral delivery of shRNA against PDK1 had no effect
on cellular survival, further confirming that the PI 3-K/Akt pathway is not necessary for GDNF-
mediated survival of sympathetic neurons (Figure 4B).
Another candidate group of signaling intermediates that could be important for GDNF-
mediated neuronal survival are the MAPK family members ERK1/2. We used U0126, a highly
selective inhibitor of MEK1/2, the kinases upstream of ERK1/2. U0126 did not prevent the
pro survival effect of GDNF, at doses that effectively blocked phosphorylation of ERK1/2
(Figure 4C). Very high doses of U0126 (25 μM) reduced cell survival after one week of
treatment, suggesting a toxic effect of the drug. PD98059, the second MEK inhibitor used, also
failed to block the survival of these neurons in the presence of GDNF (data not shown).
Therefore, since two structurally unrelated MEK inhibitors did not prevent cell survival, it is
unlikely that any of these kinases participate in the pro survival effects of GDNF. In
experiments using both PI 3-K and MEK1/2 inhibitors we replaced the medium every 24 hours
to ensure sustained blockade of the pathways. As shown in Supplemental Figure 1, both
inhibitors efficiently blocked activation of their respective targets after 24 hours of stimulation.
The PI 3-K/Akt pathway supports cell growth
As sympathetic neurons mature in the presence of NGF, they progressively increase their size
and become independent of NGF for survival. Thus, in mature neurons NGF is required to
stimulate the anabolic metabolism of the cell but not its survival 9, indicating that cell growth
and cell survival are regulated independently in these neurons. Silencing of PDK1, although
not causing cell death, resulted in a marked reduction in the soma diameter of these neurons,
indicating that PI 3-K signaling stimulates cell growth (Figures 5A and 5B). Consistent with
this observation, neurons from RetRET9(Y981F) animals increased their size over time in the
presence of GDNF at a much slower rate than those from either RetRET9 or RetRET9(Y1015F)
mice (Figure 5C but see also Supplemental Figure 2). Therefore, as is the case for NGF 6 it
appears that GDNF relies on the activation of the PI 3-K/Akt pathway to stimulate cell growth
of sympathetic neurons.
Neurotrophic factor-induced neuronal survival of sympathetic neurons is mediated by B-Raf
The lack of phosphorylation of ERK1/2 in neurons from RetRET(Y1062F) mice correlated with
the failure of GDNF to support survival of these sympathetic neurons, whereas in neurons from
mice carrying either Ret Y981F or Y1015F this pathway, while diminished, was still active.
Although experiments with U0126 ruled out a role of ERK1/2 in neuronal survival, it was still
possible that apical elements of the pathway, such as Ras or Raf could be involved in the pro
survival effects of GDNF, in a MEK-independent fashion. Lentiviral delivery of shRNAs
against A-Raf, B-Raf and C-Raf effectively blocked the expression of each family member
(Figures 6A, B and C). However, the protective effects of GDNF in cultured sympathetic
neurons were only reversed by decreasing B-Raf levels. Importantly, knockdown of B-Raf
killed sympathetic neurons also in the presence of NGF (Figure 6D). Finally, overexpression
of a constitutively active form of B-Raf (V600E) was able to rescue trophic factor-deprived
sympathetic neurons from death (Figure 7A). This observation is consistent with a critical role
of B-Raf in neurotrophic factor-mediated survival of sympathetic neurons.
IKKs are downstream effectors of B-Raf in sympathetic neurons
Currently it is unclear by which mechanism Raf kinases promote their biological effects
independently of MEK-1/2. Several putative Raf targets such as MTS-2, Rok-α, Bad and the
NF-κB pathway had been proposed (reviewed in 10,11). We chose to test the latter because
the NF-κB pathway has been reported to block apoptosis in sympathetic and sensory neurons
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12,13. In the so-called canonical NF-κB pathway, activated IKK complex formed by two
catalytic subunits (IKKα and IKKβ) and a regulatory subunit (IKKγ) phosphorylates the
inhibitors of NF-κB (IκB) which become degraded by the proteasome. Degradation of IkB
frees cytoplasmic NF-κB dimers which translocate to the nucleus to activate transcription of
target genes. As shown in figure 7B, simultaneous silencing of both IKKα and IKKβ, but not
inhibition of PI 3-K or MEK-1/2, reversed the protection afforded by V600E B-Raf, suggesting
that IKKs are downstream effectors of B-Raf. To further confirm this notion, we examined
whether NGF or GDNF were able to activate IKKs in a B-Raf-dependent manner. Both
neurotrophic factors induced phosphorylation of IKKα and IKKβ in their activation loop
(Figure 7C). Silencing of B-Raf prevented phosphorylation of IKKs, indicating that activation
of IKKs by NGF or GDNF requires B-Raf (Figure 7C). Finally, we tested whether B-Raf and
IKKs form a complex in sympathetic neurons. As shown in Figure 7D, endogenous B-Raf co-
immunoprecipitated with endogenous IKKα or IKKβ independently of trophic factor
stimulation, indicating that IKKs and B-Raf are constitutively associated in these neurons.
Interestingly, our preliminary results indicate that such binding is retained in organs from
newborn mice such as brain, heart or skin (data not shown), suggesting that the B-Raf/IKK
pathway could operate in other cell types outside the nervous system. Taken together, these
results place IKKs as downstream targets mediating the pro-survival effects of B-Raf.
IKKs are necessary for NGF- and GDNF-mediated survival of sympathetic neurons
Having shown that silencing of IKKs prevents the survival effects of V600E B-Raf, we wanted
to ascertain next whether IKKs are necessary for neurotrophic factor-induced survival of
sympathetic neurons. Silencing of IKKs in conjunction or individually (Figure 8 A and B,
respectively) killed sympathetic neurons maintained in the presence of either NGF or GDNF,
indicating that both IKKα and IKKβ are necessary for neuronal survival triggered by NGF or
GDNF. Such phenomenon was not restricted to mouse sympathetic neurons, as rat sympathetic
neurons or mouse trigeminal neurons also died when either IKKs or B-Raf were silenced
(Supplemental Figure 3). Silencing of IKKβ caused an increase in BimEL and PUMA levels
in the presence of NGF, to levels comparable to those reached after NGF deprivation (Figure
7C). On the other hand, knockdown of Bax suppressed cell death caused by both NGF
deprivation and lack of IKKβ (Figure 7D). These results therefore suggest that cell death caused
by loss of IKK signaling mimics trophic factor withdrawal-induced cell death14. Finally, we
checked the status of IKKs in sympathetic neurons from RetRET(Y981F) and RetRET(Y1062F)
mice. As expected, mutation of tyrosine 1062 completely prevented activation of IKKs,
whereas lack of tyrosine 981 had little or no effect (Figure 8E).
DISCUSSION
Regulation of the PI 3-K/Akt and the ERK1/2 pathways by Ret tyrosines
Absence of tyrosine 1062 results in blockade of phosphorylation of both Akt and ERK1/2 to
baseline. Importantly, B-Raf is the major MEK kinase in sympathetic neurons (Supplemental
Figure 2), indicating that Ret9(Y1062F) is unable to activate B-Raf upon GDNF stimulation.
Ret activates both the PI 3-K/Akt pathway and the Ras/ERK pathway via recruitment of the
adaptor protein Grb2 to phosphorylated Shc and/or FRS-2 15,16. Binding of Grb2 to Gab1/2
activates the PI 3-K/Akt pathway whereas binding of Grb2 to Sos activates ERK1/2 via Ras-
Raf-MEK. As mentioned earlier, both Shc and FRS-2 bind to phosphotyrosine 1062 and
therefore its absence would impair the phosphorylation of such adaptors and its subsequent
binding to Grb2. How Tyr981 regulates these pathways in the case of Ret signaling is unclear
but many possibilities exist, such as phosphorylation of Dok6 via a Src family kinase 17,18,
tyrosine phosphorylation of Akt by Src 19 or inhibition of PTEN activity by a Src familiy
kinase 20. In any case, the mechanisms by which these tyrosines regulate downstream signaling
needs to be further explored.
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The role of PI 3-K/Akt in neuronal survival
Our data does not support a significant role of the PI 3-K/Akt pathway in GDNF-mediated
neuronal survival of sympathetic neurons.. Although PI3-K has been shown to exert anti-
apoptotic effects in many paradigms, its role in the survival of sympathetic neurons is
controversial. The most thoroughly examined neurotrophic factor in this paradigm is NGF.
Some authors have reported that blockade of PI 3-K function by different means prevents NGF-
mediated survival 3, 4 whereas others have shown the opposite 5,6. The reason for these
discrepancies is unclear but it is probably related to both the culture conditions and methods
for assessing survival. For example, evaluation of survival relying solely on metabolic assays
such as MTT reduction could be misleading since inhibition of PI 3-K reduces the cell size and
metabolic activity of these cells (our data, 6). Likewise, the use of exceedingly high doses of
LY294002, well above those needed to completely inhibit PI 3-K, might cause cellular toxicity
or affect other targets than PI 3-K itself. Finally, blockade of PI 3-K does not trigger the
apoptotic molecular events that take place in NGF-deprived SCG neurons such as Bax
translocation to the mitochondria or release of cytochrome c to the cytosol14, further indicating
that inhibition of PI 3-K does not completely mimic absence of trophic support 6.
Control of cell growth by the PI 3-K/Akt pathway
Knockdown of PDK1, although not affecting cell survival, caused a marked reduction in cell
size. Likewise, lack of Ret tyrosine 981, which resulted in an almost complete blockade of Akt
phosphorylation, caused a reduction in cell size without affecting survival. Interestingly, mice
expressing a hypomorphic mutation for PDK1 are viable and are fertile but have reduced body
mass ultimately caused by a decrease in cell size but not in cell number 21. Moreover,
fibroblasts from these animals undergo apoptosis at the same rate than those from wild type
animals.
We hypothesize that control of cell size by PI 3-K is linked to the activation of mTOR, a kinase
which plays a well-known role in both nutrient sensing and stimulation of anabolism and cell
growth. The connection between mTOR and the PI 3-K/Akt has been recently unveiled in the
case of the insulin/IGF system, by the finding that Akt phosphorylates and inactivates the
TSC1/TSC2 complex, an inhibitor of mTOR activity (reviewed in22). Thus, inhibition of PI
3-K would result in repression of mTOR signaling, thereby reducing or stopping GDNF-
mediated cell growth.
B-Raf as a key mediator of survival
Our data indicate that B-Raf is necessary for GDNF- and NGF-mediated survival in
sympathetic neurons, independently of MEK. This is consistent with data from Wiese and
colleagues, who showed that targeted deletion of B-Raf prevented neurotrophin-mediated
survival of embryonic motor and sensory neurons 23. In that work, the authors also show that
lack of B-Raf causes a decrease in expression of IAPs, especially XIAP. These observations
are in agreement with those reported by Kato and colleagues, who demonstrated that IAPs are
essential for GDNF-mediated survival of embryonic motor neurons 24. Accordingly, we also
observed a decrease in XIAP levels concomitant with silencing of B-Raf in our system
(Supplemental Figure 4). However, sympathetic neurons from XIAP−/− mice survive normally
in the presence of NGF 25, indicating that loss of XIAP expression by itself is not sufficient
to preclude NGF-mediated survival of these neurons (see below). A recent report suggests that
B-Raf is not necessary for survival of sensory neurons but instead regulates axon growth in
vivo 26. We do not know whether these differences are cell specific or on the contrary are due
to functional redundancy between family members, or perhaps to incomplete excision of Raf
at the onset of programmed cell death of DRG neurons.
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Finally, it is worth noting that the central role of B-Raf as an effector of Ret signaling appears
to be conserved outside the nervous system, as the RET-RAS-BRAF pathway has been
identified as one of the major genetic alterations found in thyroid carcinomas, being its
activation responsible for the proliferation and invasive phenotype of these cells27.
How do IKKs regulate neuronal survival?
One of the major findings of this paper is that IKKs are targets of B-Raf in sympathetic neurons,
and that IKK activity is necessary for NGF and GDNF-mediated survival of these neurons.
Although the role of IKKs in neuronal survival has not been addressed thoroughly, results
obtained in other systems suggest a plethora of potential mechanisms by which IKKs could
block apoptosis. First, anti-apoptotic genes such as Bcl-2 family members A1/Bfl-1, Mcl-1
and Bcl-XL, or IAPs such as XIAP are found among transcriptional targets of NF-κB 28.
Second, IKKs can block the JNK pathway via activation of NF-κB. It is well established that
activation of the JNK pathway is necessary for trophic factor withdrawal-induced death of
sympathetic neurons,29–32. Blockade of the JNK pathway can be accomplished directly by
inducing the expression of antagonists of the pathway such as Gadd45β (which blocks the
activity of MKK7) 33,34. It can also be blocked indirectly by inducing the expression of
antioxidants such as ferritin heavy chain 35, that counteract the production of reactive oxygen
species concomitant to some types of cell death, including that occurring in sympathetic
neurons after NGF withdrawal 36,37. Third, IKKs may exert their protective effects
independently of IκBα degradation and NF-κB activation. Thus, it has been shown that
IKKβ contributes to tumor development by directly phosphorylating and inducing ubiquitin-
dependent degradation of the transcription factor FOXO3A 38. Interestingly, it has been shown
that Bim is under the transcriptional control of FOXO3A 39 (although Bim levels can be
regulated via other transcriptional and post-transcritpional mechanisms), and that Bim deletion
attenuates trophic factor withdrawal-induced death of sympathetic neurons 39 The contribution
of all these potential mechanisms to blockade of sympathetic neuronal cell death by IKKs is
currently being investigated.
EXPERIMENTAL PROCEDURES
Antibodies and reagents
Antibodies to Ret9 (C-19G), Ret51(C-20G), A-Raf (C-20G), and B-Raf (F-7) were from Santa
Cruz Biotechnology (Santa Cruz, CA). Antibodies to phospho-Akt (Ser473), dually
phosphorylated ERK1/2 (Thr202/Tyr204) and phospho-IKKα (Ser180)/IKKβ (Ser181) were
from Cell Signaling (Beverly, MA). Anti PDK1 and anti C-Raf were purchased from BD
Biosciences (San Jose, CA). Anti IKKα and IKKβ antibodies were from Calbiochem
(Darmstadt, Germany), and anti-Bax was from Upstate (Lake Placid, NY). The BIM and XIAP
antibodies were obtained from Stressgen (Victoria BC, Canada), and the anti alpha-tubulin was
from Sigma (St. Louis, MO). Anti-PUMA was from ProSci Inc. (Poway, CA). Finally, the
antibody against the extracellular domain of Ret has been previously described 17. LY294002,
PD98059 and U0126 were from Calbiochem. All other reagents were from Sigma.
Cell culture and assessment of neuronal survival
Mouse sympathetic neurons from the superior cervical ganglion of postnatal day 0–1 pups were
dissected and cultured essentially as described 40. Briefly, ganglia were sequentially digested
in collagenase and trypsin (Worthington Lakewood, NJ), dissociated by trituration and plated
on rat tail collagen-coated dishes in the medium containing 50 ng/ml NGF (Alomone labs,
Jerusalem, Israel), 10% fetal bovine serum (Invitrogen, Carlsbad, CA) and anti-mitotics for 5
days (AM0 medium). Subsequently cells were washed three times with media and switched to
media containing either anti-NGF, 50 ng/ml NGF (Alomone) or anti-NGF plus 50 ng/ml GDNF
(Alomone) and 100 ng/ml Fc-GFRa1 (R & D Systems, Minneapolis, MN). For survival
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experiments, one tenth to one fifth of a ganglion was plated in 24-well dishes. Neuronal survival
was assessed by counting neurons of designated fields before and after treatments at the
indicated time points. Typically, around 200–300 neurons per field were counted in triplicate
wells. Results were expressed as a percentage of the initially counted cells. Experiments were
repeated at least three times, the data was pooled and expressed as mean ± standard deviation.
For measurement of somal diameter, pictures were analyzed with the AnalySIS software
package (Soft Imaging System GmbH, Germany).
Immunoprecipitation and western blot
For western blot, cells were plated at higher density (typically 1–2 ganglia per well in 24-well
or 12-well plates, respectively) and kept in NGF-containing media for 5–7 days. Then cells
were washed three times with AM0 and deprived overnight in media containing no NGF.
Neurons were stimulated with 50 ng/ml GDNF plus Fc-GFRα1 or 50 ng/ml NGF for ten
minutes. We added GFRα1 to match the culture conditions in survival experiments, even
though its presence did not alter the signaling pattern elicited by GDNF (data not shown). Cells
were lysed in NP-40 containing buffer (150 mM NaCl, 50 mM Tris pH 8, 1 mM EDTA, 1 mM
EGTA) freshly supplemented with a cocktail of protease inhibitors (Roche Applied Science),
1mM sodium orthovanadate, 10 mM sodium fluoride and 50 mM β-glycerophosphate.
Alternatively, cells were directly lysed in Laemmli’s buffer. Proteins were resolved in SDS-
PAGE, transferred to PVDF membranes (Millipore) and blocked in TBST containing 5% BSA.
Primary antibodies were incubated overnight at 4°C, followed by peroxidase-conjugated
secondary antibodies. Immunodetection was performed using ECL-Advance (Amersham, GE
Healthcare). X-ray films were scanned with an EPSON Perfection 3200 PHOTO apparatus
and acquired with Adobe Photoshop. Densitometric analysis was performed using the Quantity
One software (Bio-Rad, Hercules, CA). For immunoprecipitation, NP-40 lysates were
incubated with the indicated primary antibodies plus sepharose-bound protein A and/or protein
G (Sigma). Immunocomplexes were washed with buffer and boiled in Laemmli’s buffer.
Lentiviral delivery of short-hairpin RNAs (shRNAs)
Lentiviral-based vectors for RNA interference-mediated gene silencing (FSVsi) consisted on
a U6 promoter for expression of short hairpin RNAs and the Venus variant of YFP under the
control of an SV40 promoter for monitoring transduction efficiency. Lentiviral particles were
produced in 293T cells co-transfected by the calcium phosphate method with the above plasmid
plus plasmids coding for the envelope and the packaging systems (VSV-G and Δ8.9,
respectively). The day after transfection, 293T cells were switched to AM0 containing no anti-
mitotics and left for 2–3 days. Supernatants were then harvested, filtered through a 0.45 μm
filter, supplemented with NGF and anti-mitotics and directly applied to sympathetic neurons.
Typically, cells were infected overnight the day after or two days after dissection. In
experiments aimed to assess the efficacy of gene knockdown by immunoblot, cells were
typically kept for five days in NGF followed by 2 more days in GDNF, or alternatively 7 days
in NGF. When gene silencing was deleterious for the cells, the pan-caspase inhibitor BAF (50
μM) was added to the media 2–3 days before lysis. For overexpression of B-Raf, the human
cDNA of B-Raf containing a V600E substitution was cloned in a lentiviral expression vector
(FCMV) which contains the promoter of human cytomegalovirus. When sequential infections
were needed, cells were infected overnight with the first set of viruses, allowed to recover the
day after and infected the following night with the second set of viruses. After this second
infection, neurons were kept in NGF for three more days before proceeding with the different
experimental conditions. Viruses expected to promote beneficial effects on survival (i.e.,
V600E B-Raf and Bax shRNA) were infected first, whereas viruses expected to have
deleterious effects were infected afterwards.
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Sequences of shRNAs
The following sequences were used for generation of shRNAs: PDK1: 5′-
TGGTGAGGTCCCAAACTGA-3′, PDK1 control: 5′-GGGAATTTCCTAAGGACGC-3′,
A1: 5′-CCTATGGTGTTGTGCTCTAT-3′, A2: 5′-TGCGTTGACATGAGTACCAA-3′; B1:
5′-GCTACCTTATTCAAACATCAA-3′, B2: 5′-GCTTACGAGAAATACACTGAA-3′; C-
Raf, C1: 5′-CCTATGGTGTTGTGCTCTAT-3′, C2: 5′-TGCGTTGACATGAGTACCAA-3′;
Raf Control: 5′-GTCCGGTTCGTTTAGAGTCTT-3′; IKKα: 5′-
CAGGCTCTTTCAGGGACAT-3′; IKKβ: 5′-GCTGCACATTTGAATCTGTAT-3′; IKK
control: 5′-GCTCTCTTGAAGGTTGATGTA -3′; Bax 5′-GCAGCTGACATGTTTGCTGAT
-3′, Bax control 5′-ACTGCCTTGGACTGTGTCTTT -3′
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Neurons from knockin mice expressing only Ret9 or Ret51 display similar responses to GDNF.
(A) Ret knockin mice express the expected splice isoforms. Lysates from sympathetic neurons
from knockin mice expressing human, wild type Ret9 or Ret51 were immunoprecipitated with
the indicated isoform-specific antibodies and probed with a Ret antibody raised against the
extracellular domain of the receptor (total Ret). Note the difference in electrophoretic mobility
between Ret9 and Ret51. (B) Signaling from neurons expressing only Ret9 or Ret51 is
indistinguishable from that of wild type neurons. Cells were stimulated for 10 minutes with
GDNF and lysates were probed with phosphospecific antibodies to phosphor-Ser473 Akt and
dually phosphorylated ERK1/2. (C) GDNF fully rescues sympathetic neurons from both
RetRET9 and RetRET51 knockin mice. Neurons from each genotype were cultured in NGF for
five days, and then incubated with media containing a blocking anti-NGF antibody, NGF or
GDNF. Neuronal survival was scored 48h later as described in the Methods section. The
number in parenthesis depicts the number of animals analyzed.
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Figure 2.
Mutation of Ret tyrosines 981, 1015 or 1062 differentially affects GDNF-mediated
downstream signaling. Representative immunoblots of phospho-Ser473 Akt and dually
phosphorylated ERK1/2 from sympathetic neurons from RetRET9(Y981F) (A), RetRET9(Y1015F)
(B) or RetRET9(Y1062F) mice (C). For comparison, WT littermates are shown. Lack of tyrosine
981 caused an almost complete abrogation of Akt phosphorylation and reduced ERK
phosphorylation to a lesser extent. In RetRET9(Y1015F) animals both Akt and ERK
phosphorylation was decreased approximately 50%, whereas mutation of tyrosine 1062
blocked both Akt and ERK phosphorylation to basal levels. Right panels show densitometric
analysis of the indicated number of independent experiments. Data are expressed as mean
±S.E.M. of fold induction. Asterisks depict p<0.05 by two tailed t-test.
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Figure 3.
Only neurons from RetRET9(Y1062F) mice fail to survive in presence of GDNF. Quantification
of the survival response to GDNF of sympathetic neurons from mice lacking tyrosine 981
(A,B), tyrosine 1015 (C,D) or tyrosine 1062 (E). The graphs on the left (A,C,E) depict survival
48 h after switching cells to GDNF, whereas the right panels (B,D) shows the same cultures
one week after switch. NGF-supported neurons were used as a control. The survival was
compared to those of wild type littermates. Number in parenthesis depicts the number of
animals of each genotype analyzed.
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Figure 4.
Neither PI 3-K/Akt nor ERK1/2 are necessary for GDNF-mediated survival. (A) Sympathetic
neurons from wild type mice were cultured for five days in NGF and then switched to GDNF
with or without the indicated doses of the PI 3-K inhibitor LY294002. Neuronal survival was
assessed 48h and 5 days after switch (left panel). In the right panel, lysates from neurons
stimulated with GDNF in the presence of the indicated doses of LY294002 were probed with
an anti-phospho-Ser473 Akt. (B). Neurons were infected with lentiviruses expressing short
hairpin RNA (shRNA) against PDK1 as specified in methods. Neurons were kept in NGF for
six days and then switched to the indicated treatments. Neuronal survival was scored at the
indicated time points after switch (left panel). In the right panel, the efficiency of the
knockdown as well as the phosphorylation of Akt was assessed by western blot. (C) Cells were
treated as in A but with the indicated doses of the MEK inhibitor U0126. Survival was assessed
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after 48h and 7 days after treatment (left panel). Right panel, lysates were probed with an
antibody to dually phosphorylated ERK1/2 to check the efficacy of the inhibitor.
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Figure 5.
(A, B) Knockdown of PDK1 reduces cell growth. Wild type mouse sympathetic neurons were
infected with lentiviruses expressing shRNA to PDK1 as in Figure 6. Pictures were taken after
14 days in culture using a fluorescence microscope to show both the morphology and the degree
of infection by visualizing expression of YFP. In B, the soma diameter was measured as
described in material and methods. (C) Loss of Ret tyrosine 981 reduces cell growth.
Sympathetic neurons from knockin mice expressing either Ret9, Ret9(Y981F) and Ret9
(Y1015F) were kept in NGF for five days, then switched to GDNF and maintained for seven
additional days. Soma diameter was measured at the time of GDNF addition and seven days
after, and the percentage of increase of somal size over this period of time calculated.
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Figure 6.
Knockdown of B-Raf, but not A-Raf or C-Raf, prevents GDNF-and NGF-mediated survival
of wild type mouse sympathetic neurons. (A,B,C) Left panels, neurons were infected with
lentiviruses expressing shRNAs to A-Raf (A1 and A2), B-Raf (B1 and B2) and C-Raf (C1 and
C2) one day after plating as described in Methods. Neurons were cultured in NGF for five days
and then switched to GDNF. Survival was assessed after 48h in the presence of GDNF. Right
panels, the efficacy of the knockdown was assessed by immunoblot using isoform-specific Raf
antibodies. In the case of B-Raf, cells were saved by the addition of the pan caspase-inhibitor
BAF 2 days before lysis (D) Same as in B but cells were treated with NGF instead of GDNF.
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Figure 7.
IKKα and IKKβ are downstream effectors of B-Raf. (A) A constitutively active form of B-Raf
(V600E) rescues trophic factor-deprived neurons. Left, cells were infected with a lentiviral
construct coding for human V600E B-Raf or empty vector. Four days later, cells were switched
to media containing a blocking anti-NGF antibody or GDNF. Survival was assessed after 48h
in the presence of GDNF. Right, V600E B-Raf mutant is constitutively active. Cells infected
with V600E B-Raf or empty vector were stimulated with for 10 minutes with GDNF and lysates
probed with antibodies to B-Raf and dually phosphorylated ERK1/2. (B) Silencing of IKKs,
but not inhibition of PI 3-K or MEK, reverses the protection afforded by V600E B-Raf. Cells
were sequentially infected as described in methods with V600E B-Raf, and either control
shRNAs or a mixture of shRNAs to IKKα and IKKβ (“α+β”). Three days after cells were
deprived and kept in the presence of the indicated inhibitors (10 μM each) two additional days,
after which survival was evaluated. (C) B-Raf acts upstream of IKKs. Cells were infected with
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control shRNAs or a shRNA to B-Raf (“B1”). Four days after infection, cells were deprived
overnight in the presence of 50 μM BAF. Cells were stimulated for 10 minutes with the
indicated factors and lysates probed against phospho-IKKs, B-Raf or tubulin. (D) Endogenous
IKKs and B-Raf form a complex in sympathetic neurons. Neurons were kept in NGF for five
days, deprived overnight and stimulated for 10 minutes with medium alone or containing the
indicated factor. IKKβ or IKKα were immunoprecipitated and lysates were immunoblotted
(IB) with the indicated antibodies. In the right panel, 5% of the input lysate was resolved in
parallel to IKKβ immunoprecipitates.
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Figure 8.
IKKs are necessary for NGF- and GDNF-mediated survival of sympathetic neurons. (A and
B) Neurons were infected with shRNAs to IKKs in combination (“α+ β”) or alone (“α” or
“β”) two days after plating. After three additional days in the presence of NGF, cells were
switched to the indicated factors and survival was evaluated 48 hours later. The right panel
shows efficacy of the knockdown. (C) Silencing of IKKs induces BimEL and PUMA
expression. Cells were infected the second day after plating with control shRNAs or a shRNA
to IKKβ and kept on NGF for three additional days. Cells were then deprived or kept in NGF
for 24 more hours as depicted, and BimEL and PUMA expression was assessed by western
blot. (D) Silencing of Bax rescues cells from knockdown of IKKβ. Cells were infected with
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shRNAs to Bax, and subsequently infected with control or shRNAs to IKKβ as detailed in
methods. Cells were maintained in NGF for three additional days, and switched to media
containing the indicated factors. Cell survival was assessed 48 hours later. Right panels shows
efficacy of the knockdown. (E) Loss of tyrosine 1062, but not tyrosine 981, blocks GDNF-
mediated phosphorylation of IKKα/β. Sympathetic neurons form the indicated genotypes were
cultured in the presence of NGF for five days, deprived overnight and stimulated for 10 minutes
with GDNF. Blots were probed with antibodies to phospho-IKKs. Note that due to a higher
acrylamide percentage IKKα and IKKβ were not resolved as in figure 7C.
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